News Article | February 20, 2017
BEAVERTON, Ore., Feb. 20, 2017 (GLOBE NEWSWIRE) -- Enli Health Intelligence, a leader in population health management IT and Gold Level member of Oracle PartnerNetwork (OPN), today announced it has achieved Oracle Validated Integration of Enli CareManager with Oracle Healthcare Foundation. To achieve Oracle Validated Integration, Oracle partners are required to meet a stringent set of requirements that are based on the needs and priorities of the customers. With this integration Enli is prepared to meet the needs of a broad spectrum of care delivery organizations, including health systems, provider networks, and accountable care organizations, by accelerating their time to value through pre-configured system and workflow integration. “Provider networks are reliant on increasingly diverse data types to inform the care plan,” said Enli CEO, Luis Machuca. “Our work with the Oracle Healthcare Foundation allows our customers to capture and activate the data to improve health outcomes.” “Achieving Oracle Validated Integration gives our healthcare customers the confidence that integration between Enli CareManager and Oracle Healthcare Foundation is functionally sound and performs as tested and creates additional functionality for Oracle Healthcare Foundation clients as they work to achieve population health and value-based care,” said Jonathan Sheldon, PhD, Global Vice President, Oracle Healthcare. Enli is widely recognized by leading analyst organizations as the market leader in population health management IT.1 CareManager, Enli’s enterprise-class care management and care coordination platform, enables provider organizations to pursue population health initiatives and close priority gaps in care. It has been co-developed with leading health systems, and seamlessly integrates with electronic health records and other existing systems of record. Through a process known as Knowledge to Action™, Enli curates and codifies the latest evidence-based medical guidelines and programs within CareManager and then delivers them to the point of care, wherever that may be. “As the population health management market has matured, the need for an enterprise grade infrastructure for data aggregation and data warehousing combined with the functionality provided by specialty vendors has become critical. Healthcare organizations will not be able to scale their value-based health initiatives without these integrated capabilities,” said Cynthia Burghard, research director at IDC Health Insights. “The collaboration between Enli Health Intelligence and Oracle gives the industry the technology needed to expand their at-risk contracts. Enli gains the scale necessary to meet the needs of the large healthcare enterprise and accountable care organizations. The relationship bodes well for Oracle, as well, in that it provides its global customer base with a proven PHM solution.” About Enli Enli Health Intelligence™ is the market leader in population health management technology. Enli enables care teams to perform to their full potential by integrating healthcare data with evidence-based guidelines embedded in provider workflows across the population and at the point of care.2 About Oracle Validated Integration Oracle Validated Integration, available through the Oracle PartnerNetwork (OPN), gives customers confidence that the integration of a complementary partner software product with an Oracle “on-premises” Application has been validated and the products work together as designed. This can help customers reduce risk, improve system implementation cycles, and provide for smoother upgrades and simpler maintenance. Oracle Validated Integration applies a rigorous technical process to review partner integrations and partners who successfully complete the program are authorized to use the “Oracle Validated Integration” logo. For more information, please visit Oracle.com at https://solutions.oracle.com/scwar/scr/AboutPartners/validated-integration/index.html About Oracle PartnerNetwork Oracle PartnerNetwork (OPN) is Oracle's partner program that provides partners with a differentiated advantage to develop, sell and implement Oracle solutions. OPN offers resources to train and support specialized knowledge of Oracle’s products and solutions and has evolved to recognize Oracle’s growing product portfolio, partner base and business opportunity. Key to the latest enhancements to OPN is the ability for partners to be recognized and rewarded for their investment in Oracle Cloud. Partners engaging with Oracle will be able to differentiate their Oracle Cloud expertise and success with customers through the OPN Cloud program – an innovative program that complements existing OPN program levels with tiers of recognition and progressive benefits for partners working with Oracle Cloud. To find out more visit: http://www.oracle.com/partners. Oracle and Java are registered trademarks of Oracle and/or its affiliates. Enli Health Intelligence, Knowledge to Action, and Better Outcomes for Everyone are registered trademarks of Enli Health Intelligence. 2 See: KLAS “Best in KLAS” 2017 and Population Health Management Performance Report 2016. See also: Chilmark 2016 Care Management Market Trends Report; IDC Marketscape: U.S. Population Health Management 2014, 2015, 2016 Vendor Assessments; and Frost & Sullivan US Population Health Management Market—Analysis and Competitive Landscape Assessment, 2016.
News Article | February 16, 2017
CarraShield Labs, Inc. reported today that Rutgers University New Jersey Medical School and Albert Einstein College of Medicine are performing a National Cancer Institute-funded study on a revolutionary way of blocking the transmission of the human papillomavirus (HPV) from person to person using Divine 9® personal lubricant. Divine 9 is made with a unique formulation of natural seaweed extracts called CarraShield® . Divine 9 with CarraShield has been shown in previous in vitro (laboratory) and in vivo (mouse) studies conducted by the National Cancer Institute to act as an HPV blocking agent. These past results were important factors that led the research team to select Divine 9 with CarraShield for this new study. Funded through a grant by the National Cancer Institute, the Rutgers and Einstein study is a combined clinical trial and translational research project to determine how well CarraShield protects against HPV. One hundred sexually active women are being recruited and then are randomly assigned to receive either Divine 9 with CarraShield as a blocking agent or an ordinary personal lubricant as a placebo. Both the Divine 9 and placebo lubricants are packaged in single-use applicators. The women are asked to use an applicator before, during or within twelve hours after a sexual encounter. Each participant is tested monthly for a wide range of HPV types to determine if CarraShield is able to protect against acquiring new HPV infections. The principal investigator for the study is Dr. Mark Einstein, Chair of the Department of OB/GYN & Women’s Health and Assistant Dean of the Clinical Research Unit at Rutgers New Jersey Medical School. In 2015, Dr. Einstein launched the initial study on CarraShield at the Albert Einstein College of Medicine (AECOM) in conjunction with the Montefiore Medical Center in New York City. Dr. Einstein is collaborating with a distinguished group of experts from AECOM including Robert Burk, M.D., Vice Chair for Translational Research and Professor of Pediatrics, and Professor of Microbiology & Immunology, of Obstetrics & Gynecology and Women’s Health, and of Epidemiology & Population Health. Dr. Burk is an expert on detecting and characterizing HPV in clinical samples. According to the World Health Organization (WHO), HPV is the cause of essentially all cervical cancers (>99%) and cervical cancer is the second most common cancer in women worldwide by age-standardized incidence rate. More than 85% of cervical cancer deaths are in developing countries, where it accounts for 13% of all female cancers. WHO also estimates that HPV causes 90% of anal cancer cases. In a separate study on HPV and throat cancer, AECOM found that the presence of an HPV type in the mouth increases the odds of developing head and neck cancer by twenty-two times. HPV is also the underlying cause of all genital warts. Current approaches to HPV prevention have limitations. While great strides have been made in creating HPV vaccines, most adults are not able to benefit because they are approved only for those aged 26 and younger. The vaccines can also be too expensive for widespread distribution in developing countries. Unfortunately, condoms are not always effective in preventing HPV infection due to the fact that HPV is transferred through skin to skin contact. A safe, effective product in the form of a personal lubricant that can be applied before, during or after sexual activity would allow people to protect themselves in a pleasant and unobtrusive fashion. “People around the world need an accessible and affordable way to protect themselves from the misery and heartache that HPV infections can cause,” stated Dean Fresonke, CEO of CarraShield Labs. “With a successful outcome from this study, we will have made significant progress toward an entirely new approach to helping prevent cervical cancer, genital warts and the other health issues caused by HPV.” CarraShield Labs, Inc., combines nature with science to create products that improve sexual well-being. Intensive research has led to the company’s proprietary, naturally-derived sea algae concentrate called CarraShield®. Divine 9® personal lubricant, made with CarraShield, was shown to block transmission of cancer-causing HPV infection in National Cancer Institute laboratory studies and is now undergoing clinical trials on women and men at McGill University. With the announcement of the new studies at Rutgers Medical School and Albert Einstein College of Medicine, the only studies in the world on HPV prevention with a personal lubricant use Divine 9 with CarraShield. While the health benefits of CarraShield are being studied, consumers can enjoy the exotic, sensual feel of Divine 9 personal lubricant today. Look for Divine 9 and other products made with CarraShield in health conscious stores and websites. Learn more at http://www.CarraShieldLabs.com.
News Article | February 15, 2017
The American Board of Quality Assurance & Utilization Review Physicians is pleased to announce the selection of Tabassum Salam, MD, FACP, CHCQM as the recipient of the 2017 CHCQM Diplomate Achievement Award. Congratulations to Dr. Salam who demonstrated an outstanding example of an IT-enabled care coordination system: the Care Link team. Beginning with the development of clinical pathways to standardize the treatment of surgical patients, robust inter-professional care coordination and discharge planning, and the proactive interaction with the Delaware and Maryland Health Information Networks, this Population Health Management project led to positive outcomes in an impressive population of post-surgical patients. Integrating data exchange into clinical workflow is an impressive task; leveraging this data with predictive modeling into a reduction in length of stay, enabling more patients to return directly home after surgery, and reduced readmissions is outstanding. Dr. Salam proudly states that, “The development of the IT innovations for Population Health Management positioned our clinical and care coordination teams to make meaningful and timely contributions to the success of patients who underwent knee and hip replacement surgery in this project. The IT innovations as well as the relationships developed by the clinical and care coordination teams broke down significant communication barriers between the many providers, health systems and post-acute agencies that contribute to the patients' care. The use of a shared population health management electronic health record allow a geographically dispersed team to collaborate on the care of the patients and avoid redundancy of efforts. In addition, the novel real-time admission, discharge and laboratory results feeds from the state health information exchanges arm the whole team with tremendously valuable, actionable alerts that had never been available before.” Patient care innovations under Dr. Salam’s leadership make the impressive work at Christiana Care a benchmark for the rest of the nation. The project clearly embodies the health care quality and management and patient safety principles ABQAURP was looking for in the award selection process. Aligned with our mission, the Care Link team found, “In addition to the technological advances, we did not forget to emphasize the building of relationships with patients, their families and their circle of care. Our team has a much more rounded view of our patients' clinical progress and social and personal needs, and this in turn allows us to guide them to recovery in a far more streamlined manner, while minimizing unnecessary, wasteful clinical activity. We have been able to seamlessly expand this model to the care of other progressively larger and geographically distributed populations in our state.” ABQAURP’s CHCQM Award Selection Panel and association Board Members felt that Dr. Salam’s project, “incorporated all of the elements of a model quality project” and successfully “integrated health IT into clinical outcomes and set a stage for addressing the needs for Population Health and for implementing MACRA.” ABQAURP would like to extend our sincere Thank You to Dr. Salam and all who submitted their outstanding achievements in quality and patient safety that have led to improvement, positive outcomes, and the advancement of Health Care Quality Management and Patient Safety. In accepting the award, Dr. Salam graciously says, “It is wonderful to receive this award on behalf of the team at Care Link, a truly interprofessional group of Population Health clinicians and Information Technology specialists. It is through their persistent hard work that we are able to bring targeted resources to patients and their families at essential healthcare-related moments in their lives. And the best part about the Care Link team is the innovation, development, and expansion continues every day; we are able to grow the network of people benefiting from our Population Health interventions.” Join us at the 40th Annual Health Care Quality & Patient Safety Conference to congratulate Dr. Salam and celebrate all of our Diplomate’s achievements. For more event information, please visit: http://www.abqaurp.org/AnnualConference. Dr. Tabassum Salam is a board-certified Internal Medicine physician. She has been at Christiana Care Health System for over fifteen years. She spent many years as a clinician-educator and Associate Director of the Internal Medicine residency program. In this role, she practiced in both inpatient and outpatient clinical settings and educated resident physicians and medical students. Currently, Dr. Salam is a Senior Physician Advisor for Population Health at Christiana Care Health System. In this role, she leads and orchestrates population health management projects for the health system. She serves as the Medical Director of Care Link Services, leading a care coordination team of nurses, pharmacists and social workers who care for large populations throughout the state of Delaware. The Care Link team focuses on improving health outcomes and optimizing utilization of health care services in the populations it cares for. Dr. Salam also serves as the Governor of the Delaware Chapter of the American College of Physicians. About ABQAURP Celebrating our 40th year of excellence in Health Care Quality Management and Patient Safety, ABQAURP is a premier professional association providing Health Care Quality and Management (HCQM) certification, ACCME-accredited continuing medical education, and membership to health care professionals worldwide. The HCQM Certification is the only interdisciplinary health care quality and management examination administered through the National Board of Medical Examiners® (NBME®). Learn more at: http://www.abqaurp.org. “National Board of Medical Examiners®” and “NBME®” are registered trademarks of the National Board of Medical Examiners.
News Article | February 28, 2017
According to a new market research report "Population Health Management Market By Component (Software, Services), End User (Healthcare Providers, Healthcare Payers, Employer Groups, Government Bodies), Mode of Delivery (Web-based, Cloud-based, On-premise), Region - Global Forecast to 2021" published by MarketsandMarkets, this report studies the global market for the forecast period of 2016 to 2021. This market is expected to reach USD 42.54 Billion by 2021 from USD 13.85 Billion in 2016, growing at a CAGR of 25.2%. Browse 65 market data Tables and 34 Figures spread through 146 Pages and in-depth TOC on "Population Health Management Market" Early buyers will receive 10% customization on this report. The global population health management market is segmented on the basis of component, mode of delivery, end user, and region. Based on component, the Population Health Management market is categorized into software and services. The software segment is expected to command the largest share of the global population health management market in 2016. PHM software includes web-based and cloud-based solutions. The advantage of these solutions is that the service provider maintains and upgrades the software and eliminates the buyer's responsibility of server support and maintenance, which enables the buyer to focus on their core business. On the basis of end user, the global population health management market is segmented into healthcare providers, healthcare payers, employer groups, and government bodies. In 2016, the healthcare providers segment is estimated to account for the largest share of the global population health management market. The large share of this segment is attributed to the implementation of the Affordable Care Act and Hospital Readmissions Reduction Program in the U.S. (which is aimed at lowering healthcare costs by making use of novel solutions such as population health management) as well as the high demand for PHM solutions among healthcare providers owing to various benefits offered by these solutions. The Medicare initiative to penalize hospitals for unnecessary readmissions is another factor contributing to the growth of this market segment. On the basis of region, the global market is divided into North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, North America is poised to account for the largest share of the population health management market, followed by Europe and Asia-Pacific. However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period. Factors such as the implementation of a number of PHM programs to improve population health in Australia, growing medical tourism in Asia, rapidly growing healthcare industry in India, efforts taken to digitalize the healthcare system in China, investments and reforms to modernize China's healthcare infrastructure, and new outline by Japan's information and communication technology fund are driving the population health management market in the Asia-Pacific region. The implementation of the Affordable Care Act (ACA) in the U.S., government support for the prevention of diseases and adoption of HCIT, growth in geriatric population and the subsequent increase in the prevalence of chronic diseases, need for affordable treatment options due to the rising healthcare costs, and advancing IT and big data capabilities are expected to drive the growth of the market in the coming years. Cerner Corporation (U.S.), McKesson Corporation (U.S.), Allscripts Healthcare Solutions, Inc. (U.S.), Healthagen, LLC. (U.S.), OptumHealth (U.S.), IBM Corporation (U.S.), Epic Corporation, Inc. (U.S.), Conifer Health Solutions, LLC (U.S.), Health Catalyst, LLC (U.S.), Wellcentive, Inc. (U.S.), i2i Population Health (U.S.), and Verscend Technologies, Inc. (U.S.) are some of the key players in the Population Health Management Market. Patient Engagement Solutions Market by Component (Hardware, Software & Services), Delivery mode (On-Premise, Web & Cloud), End User (Provider & Payer), Applications (Home Health, Financial Health), Therapeutic Area - Global Forecast to 2020 MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets
News Article | February 15, 2017
February 13, 2017 -- A study just released by Columbia University's Mailman School of Public Health reports on the health of American women who were deployed to Vietnam for either military or civilian service. The results show that 48 percent of career military women were very happy compared to 38 percent of women in the general population, and of better than average physical and mental health. The study is the first study to describe the experiences of civilian women deployed to a warzone, compare them to those of military women and match the patterns of general health and happiness for women deployed to Vietnam with a representative sample of their peers. Findings are published online in the journal Social Science & Medicine--Population Health. In addition to positive aspects of service, adverse effects were also noted. Women who served less than 10 years in the military were more likely to report their Vietnam experience as "highly stressful" (28 percent) compared to career military women who served more than 20 years (12 percent) and civilian women (13 percent). They cited such stressors as poor living and working conditions, exposure to the consequences of war, physical threat, negative interpersonal experiences (including rape and sexual harassment), and drug and alcohol problems. About 265,000 women served in the U.S. military during the Vietnam Era, with as many as 11,000 deployed to Vietnam but not formally assigned combat roles. Nonetheless, they were deployed to combat zones where they experienced warzone stressors and hostile fire. "Our results suggest that a military career--which by military rules in force during the Vietnam era, precluded a woman from typical wife and mother roles--afforded women a meaningful experience that continued to positively impact their emotional well-being, even decades after the war," said Jeanne Mager Stellman, PhD, professor emerita of Health Policy and Management and senior author. Career military women who never had children also reported being happier than the average American woman. "Women who volunteered and went to Vietnam in the 1960s may have done so as a way of breaking away from the traditional roles assigned to women in the United States during that time, and they seem to have continued on a different trajectory in post-war years," said Dr. Stellman. Collaborating with the Vietnam Women's Memorial Project, Dr. Stellman and colleagues at the VA National Center for PTSD, VA Boston Healthcare System and Boston University School of Medicine also compared civilian women, primarily American Red Cross workers, to military women and studied how warzone experiences, exposure to casualties and sexual harassment, affected their current health. They also compared the deployed women to women of comparable age in the General Social Survey, a widely used representative study of Americans. Both military and civilian women who served in Vietnam, regardless of whether they continued to make the military their career, were less likely to have married or have had children than women from the general population. Deployment to Vietnam for both military and civilian women had other positive aspects. Many women reported satisfaction from their work with the wounded troops and civilians in Vietnam. Those who served as nurses, in particular, commented that they were given much more responsibility in their positions while in Vietnam than they would have had in a similar civilian job in the U. S. An earlier paper by Dr. Stellman and the Boston-VA based group evaluated the psychological well-being of approximately 1,300 female military personnel, Red Cross workers, and others deployed to Vietnam. "Our new study underscores the benefits of a military career for those women who chose it," noted Dr. Stellman. "Entering military service or volunteering for civilian activities in a warzone offered an opportunity for talented women to establish careers, and rise to high ranks and achieve positions that would be impossible in the civilian world. In addition, career military women in general, lived in a supportive community that was knowledgeable and sympathetic to their work. What we learned from this study can help to improve the experiences and well-being of current and future generations of female military personnel," noted Dr. Stellman. Co-authors include Anica Pless Kaiser and Eve H. Davison, Veteran Affairs A National Center for PTSD, Veteran Affairs Boston Healthcare System and Boston University School of Medicine; Avron Spiro III, Massachusetts Veterans Epidemiology Research and Information Center, VA Boston Healthcare System and Boston University Schools of Public Health and Medicine; Daniel H. Kabat, Mailman School of Public Health, now Gold Health Strategies, Inc. The study was supported by the National Academy of Sciences (NAS-VA-5124-98-001), National Institute on Aging (R24-AG039343), and U.S. Department of Veterans Affairs (IK2 RX001832-01A2. Founded in 1922, Columbia University's Mailman School of Public Health pursues an agenda of research, education, and service to address the critical and complex public health issues affecting New Yorkers, the nation and the world. The Mailman School is the third largest recipient of NIH grants among schools of public health. Its over 450 multi-disciplinary faculty members work in more than 100 countries around the world, addressing such issues as preventing infectious and chronic diseases, environmental health, maternal and child health, health policy, climate change & health, and public health preparedness. It is a leader in public health education with over 1,300 graduate students from more than 40 nations pursuing a variety of master's and doctoral degree programs. The Mailman School is also home to numerous world-renowned research centers including ICAP (formerly the International Center for AIDS Care and Treatment Programs) and the Center for Infection and Immunity. For more information, please visit http://www. .
News Article | February 21, 2017
Innovaccer to Impact and Improve Population Health with #Connect4Care at HIMSS'17 Innovaccer Inc is a Silicon Valley-headquartered, Healthcare analytics company. Innovaccers aim is to simplify complex data originating from all points of care, streamline the information flow and help organizations make powerful decisions based on the key insights and predictions from their data. Palo Alto, CA, February 21, 2017 --( Innovaccer’s revamped platform Datashop will have built-in Referral Management, Advanced Chronic Care Management, Patient Engagement, and MACRA solutions on top of the pre-existing holistic Population Health Management suite. The Innovaccer team will be there at HIMSS'17 to share the success of its customers and what all Datashop helped them achieve, as well as talk about the company’s journey thus far in delivering better clinical and financial outcomes. “Value-based reimbursements are the new watchwords in healthcare and this is where our major focus continues to be - in improving outcomes in all health care organizations. We are working to accelerate the transition to value-based care and help our clients fill the identified gaps across their acute, ambulatory, skilled nursing and home care setups,” said Abhinav Shashank, CEO, and Co-founder at Innovaccer. “HIMSS has always been a great place to connect and learn about industry trends, share ideas, and contribute to making healthcare an affordable and equitable space,” says Abhinav. Sandeep Gupta, Co-founder & COO at Innovaccer will be presenting Datashop functionalities at a session on “7 Stages of Value-Based Reimbursement” with one of the company’s marquee clients, Mr. Mark Anderson, COO & VP of Operations of East Texas IPA. Mr.Anderson as a Healthcare Futurist with over 1,000 conference appearances on the needed improvements in healthcare will share his unique perspective on Value Based Reimbursement (VBR) system and his insight on what level of technology is required to navigate through the 7 different Stages of VBR successfully. The session will be held at 10:30 AM on February 20th, at Population Care Management Center in HIMSS’17. “I have been in the healthcare industry for over 40 years now, and clearly understand the challenges we face creating real-time knowledge and wisdom from numerous non-connected silos of information. We have moved to a Value-Based ecosystem with advanced tools offered by Innovaccer for measuring and quantifying - quality of care, outcomes, and costs. With Datashop, we were able to measure our performances and build best practice care plans, have truly coordinated care, and engage with the patients and their families to ensure we can all meet and exceed clinical and financial guidelines,” said Mark Anderson. #Connect4Care Innovaccer is putting a concerted effort into improving population health and achieve comprehensive value in care. In this pursuit, Innovaccer is going to donate $5 to Red Cross, Children International or Watsi or Save the Children or any other NGO of a visitors’ choice so that underprivileged get better care. Innovaccer with its future-proof technology, is committed to making lives healthier through its #Connect4Care initiative and invites everyone to be a part of this commitment that will create impact at scale in improving population health. Visit Innovaccer at Booth # 6179-31 in Population Care Management Center. To learn more about Datashop’s offering, schedule a personal demo. About Innovaccer Innovaccer Inc is a Silicon Valley-headquartered, Healthcare analytics company. Innovaccer’s aim is to simplify complex data originating from all points of care, streamline the information flow and help organizations make powerful decisions based on the key insights and predictions from their data. Its proprietary product, Datashop enables organizations to use data as a source of innovation and has been deployed across 15 countries at academic institutions, governmental organizations, and several corporate enterprises such as Catholic Health Initiatives, Stratifi, Catalyst, MLK Community Hospital, El Paso HIE, Sonic Healthsystems, Harvard, Stanford, MIT, and Wolters Kluwers. For more information, please visit innovaccer.com or follow us on Twitter @innovaccer. Press Contact Sachin Saxena Innovaccer Inc 650-479-4891 firstname.lastname@example.org Palo Alto, CA, February 21, 2017 --( PR.com )-- Innovaccer Inc., a Silicon Valley- Headquartered Healthcare analytics company, will be at HIMSS 2017 in Orlando, Florida to accelerate improvements in the value-based ecosystem with its revamped proprietary product, Datashop - the operating system that powers healthcare.Innovaccer’s revamped platform Datashop will have built-in Referral Management, Advanced Chronic Care Management, Patient Engagement, and MACRA solutions on top of the pre-existing holistic Population Health Management suite. The Innovaccer team will be there at HIMSS'17 to share the success of its customers and what all Datashop helped them achieve, as well as talk about the company’s journey thus far in delivering better clinical and financial outcomes.“Value-based reimbursements are the new watchwords in healthcare and this is where our major focus continues to be - in improving outcomes in all health care organizations. We are working to accelerate the transition to value-based care and help our clients fill the identified gaps across their acute, ambulatory, skilled nursing and home care setups,” said Abhinav Shashank, CEO, and Co-founder at Innovaccer. “HIMSS has always been a great place to connect and learn about industry trends, share ideas, and contribute to making healthcare an affordable and equitable space,” says Abhinav.Sandeep Gupta, Co-founder & COO at Innovaccer will be presenting Datashop functionalities at a session on “7 Stages of Value-Based Reimbursement” with one of the company’s marquee clients, Mr. Mark Anderson, COO & VP of Operations of East Texas IPA. Mr.Anderson as a Healthcare Futurist with over 1,000 conference appearances on the needed improvements in healthcare will share his unique perspective on Value Based Reimbursement (VBR) system and his insight on what level of technology is required to navigate through the 7 different Stages of VBR successfully. The session will be held at 10:30 AM on February 20th, at Population Care Management Center in HIMSS’17.“I have been in the healthcare industry for over 40 years now, and clearly understand the challenges we face creating real-time knowledge and wisdom from numerous non-connected silos of information. We have moved to a Value-Based ecosystem with advanced tools offered by Innovaccer for measuring and quantifying - quality of care, outcomes, and costs. With Datashop, we were able to measure our performances and build best practice care plans, have truly coordinated care, and engage with the patients and their families to ensure we can all meet and exceed clinical and financial guidelines,” said Mark Anderson.#Connect4CareInnovaccer is putting a concerted effort into improving population health and achieve comprehensive value in care. In this pursuit, Innovaccer is going to donate $5 to Red Cross, Children International or Watsi or Save the Children or any other NGO of a visitors’ choice so that underprivileged get better care. Innovaccer with its future-proof technology, is committed to making lives healthier through its #Connect4Care initiative and invites everyone to be a part of this commitment that will create impact at scale in improving population health.Visit Innovaccer at Booth # 6179-31 in Population Care Management Center.To learn more about Datashop’s offering, schedule a personal demo.About InnovaccerInnovaccer Inc is a Silicon Valley-headquartered, Healthcare analytics company. Innovaccer’s aim is to simplify complex data originating from all points of care, streamline the information flow and help organizations make powerful decisions based on the key insights and predictions from their data. Its proprietary product, Datashop enables organizations to use data as a source of innovation and has been deployed across 15 countries at academic institutions, governmental organizations, and several corporate enterprises such as Catholic Health Initiatives, Stratifi, Catalyst, MLK Community Hospital, El Paso HIE, Sonic Healthsystems, Harvard, Stanford, MIT, and Wolters Kluwers.For more information, please visit innovaccer.com or follow us on Twitter @innovaccer.Press ContactSachin SaxenaInnovaccer Inc650email@example.com Click here to view the list of recent Press Releases from Innovaccer
Pekmezaris R.,Population Health
Telemedicine journal and e-health : the official journal of the American Telemedicine Association | Year: 2012
To study the impact of remote patient monitoring (RPM) upon the most frequent diagnosis in hospitalized patients over 65 years of age-heart failure (HF). We examined the effect of RPM on hospital utilization and Medicare costs of HF patients receiving home care. Two studies were simultaneously conducted: A randomized and a matched-cohort study. In the randomized study, 168 subjects were randomly assigned (after hospitalization) to home care utilizing RPM (live nursing visits and video-based nursing visits) or to home care receiving live nursing visits only. In the matched-cohort study, 160 subjects receiving home care with RPM (live nursing visits and video-based nursing visits) were matched with home care subjects receiving live nursing visits only. Regardless of whether outcomes were being analyzed for all subjects (intention to treat) or for hospitalized subjects only, hospitalization rates, time to first admission, length of stay, and costs to Medicare did not differ significantly between groups in either study at 30 or 90 days after enrollment. A notable trend, however, emerged across studies: Although time to hospitalization was shorter in the RPM groups than the control groups, RPM groups had lower hospitalization costs. RPM, when utilized in conjunction with a robust management protocol, was not found to significantly differ from live nursing visits in the management of HF in home care. Shorter hospitalization times and lower associated costs may be due to earlier identification of exacerbation. These trends indicate the need for further study.
News Article | February 22, 2017
VitreosHealth Predictive HCC Risk Adjustment solution leverages advanced data analytics to accurately understand each Medicare Advantage member’s risk, identify any gaps-in-coding, as well as gaps-in-care to ensure proper reimbursement for a given population. This new solution helps transform the HCC Risk Adjustment process from a typical fragmented process to a technology-enabled process utilizing advanced predictive analytics. HCC Risk adjustment is one of the top untapped opportunities for an HMO or Provider group taking on risk with Medicare, Medicaid, or dual-eligible contracts. Accurate HCC coding information helps create a more complete picture of the complexity of a patient population and improve premium revenue capture while maintaining compliance “Some of the biggest challenges faced are related to coding analyst productivity and premium revenue loss. The integrated workflows with embedded analytics helped increase our productivity by 25% and reduced our undercoding by 15%,” said Carey Ketelsen, Executive Director, GlobalHealth. “VitreosHealth organized data-driven risk adjustment process helped us increase our revenue capture by $2.5 million within the first six months.” VitreosHealth also announced its first free State-of-Health Analysis (SOHA) to identify undercoding opportunities within a Medicare/Medicaid population cohort to establish a baseline for its pay-for-performance, outcomes-based pricing model to its customers. “We believe the VitreosHealth solution is 3-4 times better than any solution in the marketplace in identifying opportunities,” said Jay Reddy, CEO of VitreosHealth. “By offering free assessments with an outcomes-based pricing model, we are putting our money where our mouth is.” For more information on the VitreosHealth Predictive HCC Adjustment solution and the Pay-for-Performance program, please contact VitreosHealth. VitreosHealth offers the first Insights-as-a-Service delivery model for advanced population health analytics. They leverage Big Data and predictive and prescriptive health insights for population risk models that provide a complete view into the healthcare continuum. Their adaptive insights achieve a patient-centric focus for each perspective within a healthcare organization that leads to quality health outcomes and improves financial performance for a measurable return on investment. VitreosHealth was recently awarded Frost & Sullivan’s 2016 North America Award for New Product Innovation for Advanced Population Health Analytics Solutions.
News Article | March 2, 2017
Nationally recognized population health pioneer and bundled payment expert leads push toward coordinated care under risk-bearing bundled arrangements WAYNE, PA--(Marketwired - March 02, 2017) - Medecision, the leader in population health management solutions for risk-bearing entities, announced today the launch of Aerial™ Bundled Episode Manager. The application is designed to support Integrated Delivery Networks (IDNs) under bundled payment arrangements by helping them zero in on their riskiest patients and provide better quality, coordinated care for an entire bundled payment episode. Tamara Cull, DHA, MSW, LCSW, ACM, has joined the company to help stand up bundled payment programs within IDNs based on their unique bundled agreements and risk-bearing arrangements. CMS has identified 48 conditions for bundling that together represent about 70 percent of spending on episodes of care. With the first performance period for expanded cardiac and joint bundles starting in July, care delivery organizations must work now to develop community partners to coordinate care, track and improve quality performance to ensure compliance success, and achieve higher rates of reimbursement. Clinical and financial success under these models requires care redesign, organizing clinical efforts around the holistic patient inside and outside of the episode of care. This process looks different for every patient population and different bundled payment arrangements. Aerial Bundled Episode Manager supports care coordination around specific bundles, helping care navigators focus on risk identification, intervention and prevention. To aid Medecision in this effort, Tamara Cull, DHA, MSW, LCSW, ACM, has joined the company as the vice president, market development. Cull served as the National Director of Population Health for Catholic Health Initiatives, responsible for value-based programs and operations, as well as population health account management. She has extensive experience pioneering care management systems in acute hospital settings. Cull holds a doctorate of health administration from the Medical University of South Carolina and a master's degree in social work. "The bundled payment market is primed for growth as CMS continues to build and launch programs around mandatory bundled payment programs and other value-based arrangements," said Dr. Cull. "This represents a huge opportunity for providers to support quality improvement and optimized revenue. Medecision is committed to helping organizations develop population health programs to support unique bundled arrangements, improve patient care and optimize revenue." Aerial Bundled Episode Manager, paired with Medecision's consulting services, meets IDNs where they are in their population health management journey, enabling them to target specific bundles and take on risk in a controlled, effective way. The application helps IDNs: To learn more about how to achieve improved outcomes and lower cost through bundled payment arrangements, join our webinar, hosted by Cull, on Thursday, March 9 from 11 a.m.-12 p.m. CT with Becker's Hospital Review. For more information about Medecision, visit www.medecision.com. Leading healthcare organizations depend on Medecision's team of experienced professionals and buy-only-what-you-need suite of Aerial™ applications to power their value-based care management strategies which allow sustainable and scalable risk management. Medecision focuses on delivering precise insights on population and individual risk for optimal, evidence-based interventions. www.medecision.com
News Article | February 21, 2017
OREM, Utah, Feb. 21, 2017 /PRNewswire/ -- IMAT Solutions, a leader in delivering innovative, real-time, Healthcare Data Management and Population Health reporting solutions, announced today it has signed a new client, the Bronx Regional Health Information Organization (Bronx RHIO), a...